Science-Based Risk Intelligence for Agricultural Biological Inputs
QBIVIEW™ · FULL PLATFORM
QBIView™ produces calibrated Bayesian probability estimates of investment return for agricultural biologicals – traceable, defensible, and science-first.
Landing page · Entry Gate · Rapid Assessment · Case Log
QUADROS BIO ADVISORY INC. · BURLINGTON, ONTARIO
PROPRIETARY RISK INTELLIGENCE
Whether you’re an investor evaluating a deal, a founder stress-testing your own science, or a researcher exploring commercialization | QBIView™ Screen gives you an instant structured read across the key dimensions: biological validity, regulatory pathway, field translation probability, and more.
QBIView™ Screen is the free gateway to QBIView™ – Quadros Bio Advisory’s full proprietary due diligence framework. 30 questions. 8 minutes. A taste of what a complete assessment reveals.
Free · Confidential · No sign-up required

Our Services
01
Technical validation of startup claims before you write the check
QBIView™ Technology Assessments reveal that most biological claims fail rigorous scrutiny. Even those that pass initial evaluations often fall short in the field, after the money has been spent. Our structured, evidence-based framework covers seven analytical dimensions — biological validity, field translation probability, regulatory pathway, and team scientific depth — giving you the insight to decide whether to invest and how to structure it.
02
Ongoing research intelligence for firms making multiple biologicals bets
For firms making multiple biologicals bets, scientific blind spots compound quietly — and by the time a regulatory setback or field failure surfaces, the damage to the portfolio is already done. QBI’s ongoing research intelligence uses a scientific lens to detect hidden risks and miscalculated pathways before they become financial events. The result: a shift from reactive portfolio management to proactive risk intelligence grounded in the biology, not just the quarterly update.
03
Bridging Brazilian innovation with North American opportunity
Brazil leads the world in commercial agricultural biologicals, backed by a robust public-sector research and field trial infrastructure that most North American investors are unaware of. Quadros Bio Advisory’s expert network maintains active research relationships across Brazil’s federal university system and Embrapa, giving us early visibility into promising technologies, emerging talent, and business opportunities before they reach North American radar.
Why QBA
Is this biology real?
Why Investors and Strategic Partners Choose Quadros Bio Advisory
Dr. Patrícia de Quadros brings a scientific foundation built across four leading research universities – UFRGS (Brazil), the University of Florida (USA), the University of Toronto and the University of Waterloo (Canada) – and direct commercial experience at three startups of biologicals. This depth of experience is the backbone of every assessment QBA delivers.
A curated network of specialists in soil microbiology, regulatory affairs, agricultural IP, fermentation science, and field agronomy – assembled per engagement, not kept on retainer. The right expertise for your specific question, every time.
We know where biological technologies fail – not from models or literature alone, but from years of direct involvement in product development and commercialization across multiple continents. That accumulated experience allows QBA to ask the questions that matter most, and to recognize a miscalculated pathway before it becomes a financial event.
Brazil produces more registered biological products than any other market, backed by deeper public-sector research and field trial infrastructure. Most North American investors encounter these innovations only after valuations have climbed. QBI gets you there first.
Let’s Take Your Biological Inputs to the Next Level
Schedule a 20-minute consultation to discuss how Quadros Bio Advisory Inc. can help you de-risk your next investment.